Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition).

Zhou, Jian; Sun, Huichuan; Wang, Zheng; Cong, Wenming; Zeng, Mengsu; Zhou, Weiping; Bie, Ping; Liu, Lianxin; Wen, Tianfu; Kuang, Ming; Han, Guohong; Yan, Zhiping; Wang, Maoqiang; Liu, Ruibao; Lu, Ligong; Ren, Zhenggang; Zeng, Zhaochong; Liang, Ping; Liang, Changhong; Chen, Min; Yan, Fuhua; Wang, Wenping; Hou, Jinlin; Ji, Yuan; Yun, Jingping; Bai, Xueli; Cai, Dingfang; Chen, Weixia; Chen, Yongjun; Cheng, Wenwu; Cheng, Shuqun; Dai, Chaoliu; Guo, Wengzhi; Guo, Yabing; Hua, Baojin; Huang, Xiaowu; Jia, Weidong; Li, Qiu; Li, Tao; Li, Xun; Li, Yaming; Li, Yexiong; Liang, Jun; Ling, Changquan; Liu, Tianshu; Liu, Xiufeng; Lu, Shichun; Lv, Guoyue; Mao, Yilei; Meng, Zhiqiang

doi:10.1159/000530495

Public

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition).

Shared by NobleBlocks on Oct 1, 2023 • 12:00 AM UTC

Authors:

Jian Zhou

Huichuan Sun

Zheng Wang

Abstract

Background: Primary liver cancer, of which around 75-85% is hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people. Summary: Since the publication of...

Subject

China

Diagnosis

Guidelines

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!